Securities and Exchange Commission

Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements

Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.

Compare To Other Companies

Annual (shares)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
2,564,000	2013-05-28	10-K	2012	FY	2010-04-01	2011-03-31	CY2010
3,327,000	2014-05-27	10-K	2013	FY	2011-04-01	2012-03-31	CY2011
2,958,000	2015-05-29	10-K	2015	FY	2012-04-01	2013-03-31	CY2012
2,927,000	2016-07-01	10-K/A	2016	FY	2013-04-01	2014-03-31	CY2013
2,088,000	2017-05-30	10-K	2017	FY	2014-04-01	2015-03-31	CY2014
0	2017-05-30	10-K	2017	FY	2015-04-01	2016-03-31	CY2015
0	2017-05-30	10-K	2017	FY	2016-04-01	2017-03-31	CY2016

Quarterly (shares)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
3,168,000	2012-07-24	10-Q	2012	Q1	2011-04-01	2011-06-30	CY2011Q2
3,622,000	2012-10-26	10-Q	2012	Q2	2011-07-01	2011-09-30	CY2011Q3
3,364,000	2013-01-25	10-Q	2012	Q3	2011-10-01	2011-12-31	CY2011Q4
2,759,000	2013-07-26	10-Q	2013	Q1	2012-04-01	2012-06-30	CY2012Q2
2,975,000	2013-11-08	10-Q	2013	Q2	2012-07-01	2012-09-30	CY2012Q3
3,023,000	2014-01-31	10-Q	2013	Q3	2012-10-01	2012-12-31	CY2012Q4
2,911,000	2014-07-25	10-Q	2015	Q1	2013-04-01	2013-06-30	CY2013Q2
2,913,000	2014-10-22	10-Q	2015	Q2	2013-07-01	2013-09-30	CY2013Q3
2,982,000	2015-01-26	10-Q	2015	Q3	2013-10-01	2013-12-31	CY2013Q4
2,480,000	2015-08-03	10-Q	2016	Q1	2014-04-01	2014-06-30	CY2014Q2
2,187,000	2015-10-29	10-Q	2016	Q2	2014-07-01	2014-09-30	CY2014Q3
1,963,000	2016-02-01	10-Q	2016	Q3	2014-10-01	2014-12-31	CY2014Q4
0	2016-07-29	10-Q	2017	Q1	2015-04-01	2015-06-30	CY2015Q2
0	2016-11-02	10-Q	2017	Q2	2015-07-01	2015-09-30	CY2015Q3
0	2016-02-01	10-Q	2016	Q3	2015-10-01	2015-12-31	CY2015Q4
0	2016-07-29	10-Q	2017	Q1	2016-04-01	2016-06-30	CY2016Q2
1,717,000	2017-11-02	10-Q	2018	Q2	2016-07-01	2016-09-30	CY2016Q3
0	2017-11-02	10-Q	2018	Q2	2017-07-01	2017-09-30	CY2017Q3

All Reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements (shares)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
2,564,000	2013-05-28	10-K	2012	FY	2010-04-01	2011-03-31	CY2010
3,168,000	2012-07-24	10-Q	2012	Q1	2011-04-01	2011-06-30	CY2011Q2
3,443,000	2012-10-26	10-Q	2012	Q2	2011-04-01	2011-09-30
3,622,000	2012-10-26	10-Q	2012	Q2	2011-07-01	2011-09-30	CY2011Q3
3,413,000	2013-01-25	10-Q	2012	Q3	2011-04-01	2011-12-31
3,364,000	2013-01-25	10-Q	2012	Q3	2011-10-01	2011-12-31	CY2011Q4
3,327,000	2013-05-28	10-K	2012	FY	2011-04-01	2012-03-31
3,327,000	2014-05-27	10-K	2013	FY	2011-04-01	2012-03-31	CY2011
2,759,000	2012-07-24	10-Q	2012	Q1	2012-04-01	2012-06-30
2,759,000	2013-07-26	10-Q	2013	Q1	2012-04-01	2012-06-30	CY2012Q2
2,896,000	2012-10-26	10-Q	2012	Q2	2012-04-01	2012-09-30
2,896,000	2013-11-08	10-Q	2013	Q2	2012-04-01	2012-09-30
2,975,000	2012-10-26	10-Q	2012	Q2	2012-07-01	2012-09-30
2,975,000	2013-11-08	10-Q	2013	Q2	2012-07-01	2012-09-30	CY2012Q3
2,947,000	2013-01-25	10-Q	2012	Q3	2012-04-01	2012-12-31
2,947,000	2014-01-31	10-Q	2013	Q3	2012-04-01	2012-12-31
3,023,000	2013-01-25	10-Q	2012	Q3	2012-10-01	2012-12-31
3,023,000	2014-01-31	10-Q	2013	Q3	2012-10-01	2012-12-31	CY2012Q4
2,958,000	2013-05-28	10-K	2012	FY	2012-04-01	2013-03-31
2,958,000	2014-05-27	10-K	2013	FY	2012-04-01	2013-03-31
2,958,000	2015-05-29	10-K	2015	FY	2012-04-01	2013-03-31	CY2012
2,911,000	2013-07-26	10-Q	2013	Q1	2013-04-01	2013-06-30
2,911,000	2014-07-25	10-Q	2015	Q1	2013-04-01	2013-06-30	CY2013Q2
2,896,000	2013-11-08	10-Q	2013	Q2	2013-04-01	2013-09-30
2,896,000	2014-10-22	10-Q	2015	Q2	2013-04-01	2013-09-30
2,913,000	2013-11-08	10-Q	2013	Q2	2013-07-01	2013-09-30
2,913,000	2014-10-22	10-Q	2015	Q2	2013-07-01	2013-09-30	CY2013Q3
2,938,000	2014-01-31	10-Q	2013	Q3	2013-04-01	2013-12-31
2,938,000	2015-01-26	10-Q	2015	Q3	2013-04-01	2013-12-31
2,982,000	2014-01-31	10-Q	2013	Q3	2013-10-01	2013-12-31
2,982,000	2015-01-26	10-Q	2015	Q3	2013-10-01	2013-12-31	CY2013Q4
2,927,000	2014-05-27	10-K	2013	FY	2013-04-01	2014-03-31
2,927,000	2015-05-29	10-K	2015	FY	2013-04-01	2014-03-31
2,927,000	2016-05-31	10-K	2016	FY	2013-04-01	2014-03-31
2,927,000	2016-07-01	10-K/A	2016	FY	2013-04-01	2014-03-31	CY2013
2,480,000	2014-07-25	10-Q	2015	Q1	2014-04-01	2014-06-30
2,480,000	2015-08-03	10-Q	2016	Q1	2014-04-01	2014-06-30	CY2014Q2
2,335,000	2014-10-22	10-Q	2015	Q2	2014-04-01	2014-09-30
2,335,000	2015-10-29	10-Q	2016	Q2	2014-04-01	2014-09-30
2,187,000	2014-10-22	10-Q	2015	Q2	2014-07-01	2014-09-30
2,187,000	2015-10-29	10-Q	2016	Q2	2014-07-01	2014-09-30	CY2014Q3
2,210,000	2015-01-26	10-Q	2015	Q3	2014-04-01	2014-12-31
2,210,000	2016-02-01	10-Q	2016	Q3	2014-04-01	2014-12-31
1,963,000	2015-01-26	10-Q	2015	Q3	2014-10-01	2014-12-31
1,963,000	2016-02-01	10-Q	2016	Q3	2014-10-01	2014-12-31	CY2014Q4
2,088,000	2015-05-29	10-K	2015	FY	2014-04-01	2015-03-31
2,088,000	2016-05-31	10-K	2016	FY	2014-04-01	2015-03-31
2,088,000	2016-07-01	10-K/A	2016	FY	2014-04-01	2015-03-31
2,088,000	2017-05-30	10-K	2017	FY	2014-04-01	2015-03-31	CY2014
0	2015-08-03	10-Q	2016	Q1	2015-04-01	2015-06-30
0	2016-07-29	10-Q	2017	Q1	2015-04-01	2015-06-30	CY2015Q2
0	2015-10-29	10-Q	2016	Q2	2015-04-01	2015-09-30
0	2016-11-02	10-Q	2017	Q2	2015-04-01	2015-09-30
0	2015-10-29	10-Q	2016	Q2	2015-07-01	2015-09-30
0	2016-11-02	10-Q	2017	Q2	2015-07-01	2015-09-30	CY2015Q3
0	2016-02-01	10-Q	2016	Q3	2015-04-01	2015-12-31
0	2016-02-01	10-Q	2016	Q3	2015-10-01	2015-12-31	CY2015Q4
0	2016-05-31	10-K	2016	FY	2015-04-01	2016-03-31
0	2016-07-01	10-K/A	2016	FY	2015-04-01	2016-03-31
0	2017-05-30	10-K	2017	FY	2015-04-01	2016-03-31	CY2015
0	2016-07-29	10-Q	2017	Q1	2016-04-01	2016-06-30	CY2016Q2
0	2016-11-02	10-Q	2017	Q2	2016-04-01	2016-09-30
0	2017-11-02	10-Q	2018	Q2	2016-04-01	2016-09-30
1,717,000	2016-11-02	10-Q	2017	Q2	2016-07-01	2016-09-30
1,717,000	2017-11-02	10-Q	2018	Q2	2016-07-01	2016-09-30	CY2016Q3
0	2017-05-30	10-K	2017	FY	2016-04-01	2017-03-31	CY2016
0	2017-11-02	10-Q	2018	Q2	2017-04-01	2017-09-30
0	2017-11-02	10-Q	2018	Q2	2017-07-01	2017-09-30	CY2017Q3